Growing evidence indicates that parkinsonian disorders to some extent share a genetic background, with two key factors identified so far: the microtubule-associated tau protein gene (MAPT) and the α-synuclein gene (SNCA). This evidence concerns the gene SNCA and parkinsonian disorder.